Doctor profile · Federal record

Dr. Evan Restelli, D.O.

Pulmonary Disease Physician (CMS: Pulmonary Disease) · Pollocksville, NC

  • NPI 1003923814
  • Accepts Medicare
  • MIPS 47.6 / 100 · 2023
  • 27 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
137 Medical Ln
Pollocksville, NC 285738200
(252) 633-1010
fax (252) 224-3071
Mailing address
Po Box 896206
Charlotte, NC 282896206

Credentials & registration

NPPES · NUCC
NPI registered
August 2006 — 20 yrs on file
Profile last updated
March 17, 2017
Year of graduation
1999 — 27 yrs since
Specialty taxonomy
207RP1001X — NUCC code
State license (1)
North Carolina #2015-00180

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1003923814. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
41,764
Distinct HCPCS
10
Medicare allowed
$1,265,789
HCPCS Description Services Patients Avg allowed
J2356 Injection, tezepelumab-ekko, 1 mg 20,580 11 $18
J2182 Injection, mepolizumab, 1 mg 16,200 21 $28
99214 Established patient office or other outpatient visit, 30-39 minutes 787 473 $122
71046 X-ray of chest, 2 views 467 324 $22
96372 Injection of drug or substance under skin or into muscle 372 64 $13
71250 Ct scan of chest without contrast 370 301 $81
99215 Established patient office or other outpatient visit, 40-54 minutes 304 199 $171
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes 201 81 $114
94729 Test to examine how well the lungs exchange gases 181 176 $53
94010 Test to measure expiratory airflow and volume 179 174 $25

In context: peer comparison

Among 1 peers in Pollocksville Pulmonary Disease Physician, average services per provider: 888. This provider delivers 47× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,207
Transactions
96
Manufacturers
14
Payer (manufacturer) Industry Txns Amount
AstraZeneca Pharmaceuticals Lp 29 $664.29
GlaxoSmithKline, LLC. 19 $314.71
Inspire Medical Systems, INC. 3 $259.79
Genzyme Corporation 13 $258.98
Regeneron Healthcare Solutions, INC. 8 $193.06
Amgen INC. 5 $88.46
Insmed, INC. 4 $86.24
Grifols USA, LLC 3 $74.23
United Therapeutics Corporation 3 $72.60
Boehringer Ingelheim Pharmaceuticals, INC. 3 $66.08
Edwards Lifesciences Corporation 2 $37.84
Baxter Healthcare 2 $33.05
Merck Sharp & Dohme LLC 1 $32.08
Electromed, INC. 1 $25.59

By nature of payment

Food and Beverage
$2,017
Travel and Lodging
$190

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
2,152
Patients
768
Total drug cost
$584,521
Drug Type Claims Patients Total cost
Albuterol Sulfate Hfa (Albuterol Sulfate) Brand 464 176 $14,409
Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter) Brand 233 58 $178,722
Symbicort (Budesonide/Formoterol Fumarate) Brand 231 50 $115,407
Prednisone Generic 199 93 $567
Montelukast Sodium Generic 164 40 $2,141
Spiriva Respimat (Tiotropium Bromide) Brand 136 31 $108,312
Azithromycin Generic 133 77 $859
Ipratropium Bromide Generic 104 48 $3,539
Ventolin Hfa (Albuterol Sulfate) Brand 83 43 $5,619
Breztri Aerosphere (Budesonide/Glycopyr/Formoterol) Brand 81 18 $61,329

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Evan Restelli's medical specialty?
Dr. Evan Restelli practices Pulmonary Disease Physician in Pollocksville, NC.
Where does Dr. Evan Restelli practice?
Dr. Evan Restelli practices at 137 Medical Ln, Pollocksville, NC 285738200. Office phone: 2526331010.
What is Dr. Evan Restelli's NPI?
Dr. Evan Restelli's National Provider Identifier (NPI) is 1003923814, issued by NPPES.
Does Dr. Evan Restelli accept Medicare assignment?
Yes. Dr. Evan Restelli accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Evan Restelli commonly perform?
Top Medicare-reported procedures in 2023: Injection, tezepelumab-ekko, 1 mg (HCPCS J2356); Injection, mepolizumab, 1 mg (HCPCS J2182); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.